Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Chris Collins set to change his plea on biotech insider trading scandal, exiting House seat
6 years ago
A year into Albert Bourla’s reign, Ian Read leaves all of Pfizer in the new CEO’s control
6 years ago
Top GSK/ViiV scientist who co-invented an HIV blockbuster books a trip to biotech
6 years ago
R&D
Pharma
Speaker Nancy Pelosi to unveil bill for federally negotiated drug prices
6 years ago
Pharma
Senators to FTC: Don't let the big Celgene and Allergan buyouts hurt R&D and consumers
6 years ago
R&D
Pharma
A favorite in Alexion’s C-suite is leaving, and some mighty surprised analysts aren’t the least bit happy about it
6 years ago
Scott Gottlieb is once again joining a team that enjoyed good times at the FDA under his high-energy stint at the helm
6 years ago
Scott Gottlieb has a new board position to add to the resume — and this one is focused on a favorite subject
6 years ago
Pharma
Indian manufacturing player Jubilant poaches top Novartis BD exec to run their new biotech startup in Yardley, PA
6 years ago
Pharma
CDER chief Janet Woodcock has a message for pharma: 'It’s not working, and it won’t work in the future'
6 years ago
Pharma
Tony Coles sets sail on new neuro pursuit at Cerevel, steering Pfizer spinout as CEO
6 years ago
MIT’s star tech guru Joi Ito resigns biotech chair post in wake of Jeffrey Epstein scandal
6 years ago
Stephen Hahn, 'clear frontrunner' for FDA commish job, has met with Trump — reports
6 years ago
FDA+
Roivant's Vivek Ramaswamy is closing in on a $3B cash deal to sell control of 5 Vants — plus — to Sumitomo Dainippon
6 years ago
Deals
Ned Sharpless in final running for FDA commish with MD Anderson exec and Harvard prof — reports
6 years ago
FDA+
Korean biopharma executive indicted for allegedly conducting illegal trials on company researchers
6 years ago
Pharma
In the midst of a deal spree, Bayer turns to veteran J&J dealmaker Marianne De Backer to bring home the technology
6 years ago
Azar keen on nominating Brett Giroir, divisive assistant HHS secretary, to top job at FDA — report
6 years ago
FDA+
Top FDA exec Edward Cox jumps ship and joins Regeneron as new regulatory VP
6 years ago
Pharma
After inking a string of pipeline deals, Boehringer Ingelheim is doing a makeover of the top executive team
6 years ago
‘Absolute standout’ biopharma analyst Mark Schoenebaum has died
6 years ago
Sir Andrew Dillon, NICE's first — and only — chief executive to step down next year
6 years ago
Pharma
FDA+
MHRA to land a new interim chief executive ahead of Brexit
6 years ago
AveXis scientific founder fires back at Novartis CEO Vas Narasimhan, 'categorically denies any wrongdoing'
6 years ago
First page
Previous page
74
75
76
77
78
79
80
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit